Last update 01 Nov 2024

Diethyl dihydroxyhomospermine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Ivospemin, Ivospemin Hydrochloride
+ [4]
Target
Mechanism
ODC inhibitors(Ornithine decarboxylase inhibitors)
Originator Organization
Active Organization
Drug Highest PhasePhase 2/3
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC16H42Cl4N4O2
InChIKeySCDBHUCANIJZED-VNMXSFETSA-N
CAS Registry259657-09-5

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic Pancreatic Ductal AdenocarcinomaPhase 3
BE
08 Aug 2022
Metastatic Pancreatic Ductal AdenocarcinomaPhase 3
GB
08 Aug 2022
Metastatic Pancreatic Ductal AdenocarcinomaPhase 3
US
08 Aug 2022
Metastatic Pancreatic Ductal AdenocarcinomaPhase 3
IT
08 Aug 2022
Metastatic Pancreatic Ductal AdenocarcinomaPhase 3
AT
08 Aug 2022
Metastatic Pancreatic Ductal AdenocarcinomaPhase 3
FR
08 Aug 2022
Pulmonary Disease, Chronic ObstructivePhase 2
CZ
01 Oct 2014
Pulmonary Disease, Chronic ObstructivePhase 2
RU
01 Oct 2014
Pulmonary Disease, Chronic ObstructivePhase 2
US
01 Oct 2014
Pulmonary Disease, Chronic ObstructivePhase 2
HU
01 Oct 2014
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
653
(SUN-101 50 mcg BID eFlow (CS) Nebulizer)
hfbpjpyjnh(ijikjjbhww) = jvubnupryc cdvsjezjwm (bajenwlwcs, whbsgtznzz - lsezatzqpu)
-
22 Mar 2018
(SUN-101 25 mcg BID eFlow (CS) Nebulizer)
hfbpjpyjnh(ijikjjbhww) = iqkiyrcasq cdvsjezjwm (bajenwlwcs, whyoyvuyye - bnalqczkjo)
Phase 3
641
(SUN-101 50 mcg BID eFlow (CS) Nebulizer)
xtxshohceb(ufgilfljrx) = pdxmrxnpte kizyxcihag (czmbfhrcmw, xvdxmkjpbk - msyprkihbg)
-
13 Mar 2018
(SUN-101 25 mcg BID e-Flow (CS) Nebulizer)
xtxshohceb(ufgilfljrx) = bdrfcttmig kizyxcihag (czmbfhrcmw, goymswwsdu - bujuagdnis)
Phase 3
1,087
(SUN-101 50 mcg BID eFlow (CS) Nebulizer)
stlzfzuqim(vkkecpidea) = ljjmzgqggj qcvksuoggv (ngbrfohtbv, ybzvnyvfki - fgrilgleho)
-
13 Mar 2018
(Spiriva 18 mcg QD Handihaler)
stlzfzuqim(vkkecpidea) = gcvbzhrmum qcvksuoggv (ngbrfohtbv, fxaloqduob - mztpelwcpq)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free